Br J Pharmacol

Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.

Zamzamy M, Post S, Ip WH, ..., Altfeld M, Schloer S

Br J Pharmacol 183 (7) 1578-1601 [2026-04-00; online 2025-11-28]

Rescue of loss-of-function long QT syndrome-associated mutations in KV7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S).

Hiniesto-Iñigo I, Sridhar A, Louradour J, ..., Ottosson NE, Liin SI

Br J Pharmacol 182 (13) 2861-2877 [2025-07-00; online 2025-03-14]

Vestibular modulation by stimulant derivatives in a pentameric ligand-gated ion channel.

Karlsson E, Andén O, Fan C, ..., Delarue M, Lindahl E

Br J Pharmacol 182 (12) 2790-2802 [2025-06-00; online 2025-03-11]

Subtype-specific modulation of human KV 7 channels by the anticonvulsant cannabidiol through a lipid-exposed pore-domain site.

Pökl M, Sridhar A, Frampton DJA, ..., Delemotte L, Liin SI

Br J Pharmacol 180 (23) 2956-2972 [2023-12-00; online 2023-07-27]

Lucie Delemotte SciLifeLab Fellow

Adenosine A2A receptor antagonists: from caffeine to selective non-xanthines.

Jacobson KA, Gao ZG, Matricon P, Eddy MT, Carlsson J

Br J Pharmacol 179 (14) 3496-3511 [2022-07-00; online 2020-06-19]

Jens Carlsson SciLifeLab Fellow

Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone.

Larsson K, Steinmetz J, Bergqvist F, ..., Korotkova M, Jakobsson PJ

Br J Pharmacol 176 (24) 4625-4638 [2019-12-00; online 2019-12-28]

Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics.

Lallo A, Gulati S, Schenk MW, ..., Helleday T, Dive C

Br J Pharmacol 176 (3) 436-450 [2019-02-00; online 2018-12-13]